BioLineRx

BioLineRx

BioLineRx

BioLineRx is a clinicalstage, publiclytraded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
Type
B2b
Founded
2003
Raised
$87.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$28,750,000
Post-IPO equity - 2017
$25,000,000
Post-IPO equity - 2015
Team Size
10+
Employees
$28,750,000 Post-IPO equity
prnewswire

BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares